Patent · US Active

Rapamycin analogue

US9382266B2 · kind B2 · utility

0Cited by
6References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 21, 2012
Grant dateJul 5, 2016
Priority date—
Expiry dateDec 21, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D498/18
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There is provided inter alia a compound of formula (I) or a pharmaceutically acceptable salt thereof and its use in therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.